Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate.
Fiche publication
Date publication
janvier 1996
Journal
The Journal of rheumatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Pouchot J, Guillemin F, Coste J, Brégeon C, Sany J
Lien Pubmed
Résumé
To develop and validate a cross cultural version of the Arthritis Impact Measurement Scales 2 (AIMS2) to be used by French speaking populations.
Mots clés
Activities of Daily Living, Antirheumatic Agents, therapeutic use, Arthritis, Rheumatoid, drug therapy, Cohort Studies, Demography, Factor Analysis, Statistical, Female, France, Humans, Male, Methotrexate, therapeutic use, Middle Aged, Quality of Life, Reproducibility of Results, Sensitivity and Specificity, Severity of Illness Index, Surveys and Questionnaires
Référence
J. Rheumatol.. 1996 Jan;23(1):52-60